Rheumatoid Arthritis Quiz: Understanding Biosimilars in RA – MD Magazine

The number of biosimilars in rheumatology is growing. Test your knowledge of biosimilars with this quiz.
Is the following statement true or false?
A manufacturer developing a biosimilar will need to demonstrate that its product is highly similar to the reference product in terms of purity, chemical identity, and bioactivity, but will not need to undertake any clinical trials to demonstrate safety and efficacy.

GATHER2: Avacincaptad Pegol Significantly Slows GA Growth Over 12 Months
New Insight: A Look at OPT-302/Sozinibercept with Megan Baldwin, PhD
Rheumatoid Arthritis Quiz: Swapping Biosimilars for Reference Products in RA
New Insight: A Recap of ASRS 2023
Positive Phase 2 Data for Omilancor in Crohn Disease, Ulcerative Colitis Presented at ACG
FDA Warns Against Eye Drops from Major Brands Due to Infection Risk
2 Clarke Drive
Cranbury, NJ 08512